EMCYT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Emcyt, and what generic alternatives are available?
Emcyt is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in EMCYT is estramustine phosphate sodium. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the estramustine phosphate sodium profile page.
Summary for EMCYT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 75 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for EMCYT |
What excipients (inactive ingredients) are in EMCYT? | EMCYT excipients list |
DailyMed Link: | EMCYT at DailyMed |
Pharmacology for EMCYT
Drug Class | Alkylating Drug |
Mechanism of Action | Alkylating Activity |
Anatomical Therapeutic Chemical (ATC) Classes for EMCYT
US Patents and Regulatory Information for EMCYT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | EMCYT | estramustine phosphate sodium | CAPSULE;ORAL | 018045-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |